CD86 and lymphedema: As shown in Fig 6(A) and 6(B), CD86+ macrophages were more infiltrated in the WT group than in the SHAM group, and TRPML1 knockout could reduce macrophage infiltration during chronic inflammation, suggesting that TRPML1 knockout may attenuate lymphedema inflammation.